Page 4 - Biora Therapeutics Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biora therapeutics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biora Therapeutics Daily Today - Breaking & Trending Today

Biora Therapeutics, Inc. (NASDAQ:BIOR) Short Interest Update

Biora Therapeutics, Inc. (NASDAQ:BIOR – Get Free Report) saw a significant decrease in short interest in June. As of June 30th, there was short interest totalling 370,800 shares, a decrease of 9.6% from the June 15th total of 410,000 shares. Currently, 2.9% of the company’s shares are sold short. Based on an average daily trading […] ....

Biora Therapeutics Inc , Armistice Capital , Capital Partners , Neuberger Berman Group , Blackrock Inc , Vanguard Group Inc , Biora Therapeutics , Get Free Report , Berman Group , Biora Therapeutics Daily ,

Biora Therapeutics, Inc. (NASDAQ:BIOR) Short Interest Update

Biora Therapeutics, Inc. (NASDAQ:BIOR – Get Rating) saw a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 390,700 shares, a decline of 7.7% from the April 30th total of 423,100 shares. Approximately 3.5% of the company’s shares are sold short. Based on an average […] ....

Biora Therapeutics Inc , Blackrock Inc , Commonwealth Equity Services , York Mellon Corp , Vanguard Group Inc , Biora Therapeutics , Get Rating , Equity Services , New York Mellon Corp , State Street Corp , Therapeutics Trading Down , Biora Therapeutics Daily , Nasdaq Bior ,

WealthTrust Axiom LLC Makes New Investment in Biora Therapeutics, Inc. (NASDAQ:BIOR)

WealthTrust Axiom LLC purchased a new position in shares of Biora Therapeutics, Inc. (NASDAQ:BIOR – Get Rating) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 10,000 shares of the company’s stock, valued at approximately $33,000. WealthTrust Axiom LLC owned 0.11% of Biora Therapeutics […] ....

Biora Therapeutics Company Profile , Exchange Commission , Vanguard Group Inc , Biora Therapeutics Inc , Neuberger Berman Group , Commonwealth Equity Services , Blackrock Inc , Wealthtrust Axiom , Biora Therapeutics , Get Rating , Trust Axiom , Berman Group , Street Corp , Therapeutics Stock Down , Biora Therapeutics Daily , Nasdaq Bior , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Biora Therapeutics, Inc. (NASDAQ:BIOR) Short Interest Down 17.3% in March

Biora Therapeutics, Inc. (NASDAQ:BIOR – Get Rating) was the target of a significant decline in short interest in March. As of March 15th, there was short interest totalling 339,400 shares, a decline of 17.3% from the February 28th total of 410,200 shares. Currently, 3.9% of the company’s shares are sold short. Based on an average […] ....

Blackrock Inc , Biora Therapeutics Company Profile , Vanguard Group Inc , York Mellon Corp , Commonwealth Equity Services , Biora Therapeutics Inc , Biora Therapeutics , Get Rating , Equity Services , New York Mellon Corp , State Street Corp , Biora Therapeutics Daily , Nasdaq Bior ,

Oxford Industries (NYSE:OXM) Issues Q1 2023 Earnings Guidance

Biora Therapeutics (NASDAQ:BIOR – Get Rating) will be posting its quarterly earnings results after the market closes on Thursday, March 30th. Analysts expect Biora Therapeutics to post earnings of ($0.89) per share for the quarter. Biora Therapeutics Trading Up 4.7 % Shares of BIOR opened at $2.88 on Friday. The stock has a market cap […] ....

Biora Therapeutics Inc , Vanguard Group Inc , Blackrock Inc , York Mellon Corp , Commonwealth Equity Services , Biora Therapeutics , Get Rating , Equity Services , New York Mellon Corp , State Street Corp , Biora Therapeutics Daily , Nasdaq Bior ,